Biomerica is a medical devices business based in the US. Biomerica shares (BMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.31 – a decrease of 6.27% over the previous week. Biomerica employs 64 staff and has a trailing 12-month revenue of around $5.5 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.31 |
|---|---|
| 52-week range | $0.24 - $2.13 |
| 50-day moving average | $0.33 |
| 200-day moving average | $0.57 |
| Wall St. target price | $13.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.37 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.314 from 2024-11-22
| 1 week (2024-11-15) | -10.05% |
|---|---|
| 1 month (2024-10-25) | 6.44% |
| 3 months (2024-08-23) | -28.59% |
| 6 months (2024-05-24) | -49.84% |
| 1 year (2023-11-24) | -64.32% |
|---|---|
| 2 years (2022-11-23) | -92.29% |
| 3 years (2021-11-24) | 5.07 |
| 5 years (2019-11-22) | 2.99 |
| Revenue TTM | $5.5 million |
|---|---|
| Gross profit TTM | $446,000 |
| Return on assets TTM | -38.54% |
| Return on equity TTM | -76.48% |
| Profit margin | -111.85% |
| Book value | $0.32 |
| Market Capitalization | $5.5 million |
TTM: trailing 12 months
We're not expecting Biomerica to pay a dividend over the next 12 months.
Biomerica's shares were split on a 1:2 basis on 13 November 1994 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biomerica shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Biomerica shares which in turn could have impacted Biomerica's share price.
Over the last 12 months, Biomerica's shares have ranged in value from as little as $0.2415 up to $2.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -1.137. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.
Biomerica, Inc. , a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.